Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib

MeSH terms

• Aged
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Brain Neoplasms / complications
• Brain Neoplasms / diagnosis*
• Brain Neoplasms / drug therapy
• Brain Neoplasms / secondary*
• Carcinoma, Renal Cell / drug therapy
• Carcinoma, Renal Cell / secondary*
• Carcinoma, Renal Cell / surgery
• Disease Progression
• Drug Administration Schedule
• Fatal Outcome
• Humans
• Indazoles
• Kidney Neoplasms / pathology*
• Kidney Neoplasms / surgery
• Lymphatic Metastasis
• Magnetic Resonance Imaging
• Male
• Nephrectomy
• Pyrimidines / administration & dosage
• Pyrimidines / adverse effects
• Pyrimidines / therapeutic use*
• Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
• Sulfonamides / administration & dosage
• Sulfonamides / adverse effects
• Sulfonamides / therapeutic use*
• Treatment Outcome